Real-time enrollment status for this malignant pleural effusion clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 5:48 PM UTC
| NCT Number | NCT06016179 |
| Recruiting Status | Recruiting |
| Condition | Malignant Pleural Effusion |
| Phase | PHASE1 |
| Target Enrollment | 12 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) |
| Last Updated on CT.gov | May 22, 2025 (May 22, 2025) |
As of July 19, 2026: Clinical trial NCT06016179 is currently recruiting participants. This phase1 study for malignant pleural effusion is actively seeking new participants at 1 location across the United States. The study is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06016179 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06016179 was last updated May 22, 2025 (May 22, 2025). HelloStudys verifies this status automatically.